Patents Assigned to Morphochem
  • Patent number: 7256194
    Abstract: The present invention relates to compounds of the Formula or a pharmaceutically acceptable salt, solvate, hydrate or formulation thereof. These compounds can be used for the inhibition of Factor Xa and for the treatment and/or prevention of diseases that are mediated by Factor Xa activity.
    Type: Grant
    Filed: February 22, 2002
    Date of Patent: August 14, 2007
    Assignee: Morphochem
    Inventors: Sven Nerdinger, Thilo Fuchs, Katrin Illgen, Robert Eckl